Resources

News      Webinars      Library      Blog

Featured News

ABC Affiliate, KSTP Channel 5 News Features Physeon’s Efforts to Improve Patient Care with the VIVA Trial

Physeon GmbH, a leading developer of medical technology products for venous access, announced that its Veinplicity® Device was featured on a segment produced by ABC affiliate KSTP Channel 5.

The segment can be viewed found by going to the following link: Video

Physeon’s Chief Executive Officer Patrick Kullmann stated “I’d like to thank ABC News KSTP Channel 5’s Leah McLane for the feature on our Veinplicity Device. This feature comes on the heels of a recent growing list of good news including our recent announcement that the Mayo Clinic and Gregory Schears, M.D., were selected as a trial site and principal investigator for Physeon’s “VIVA” (Veinplicity for Improved Venous Access) trial in the United States, and that previously announced positive results from our first clinical trial were published in highly respected Journal of Vascular Access.”

All News

Featured Webinar

EU MDR: Tips for Effectively Addressing the New Requirements

Fall 2018

Learn how the history of the MDR development impacts current regulation, requirements for authorized representatives, distributors and manufacturers, the key differences between MDD and MDR, and see an overview of the chapters and annexes of the MDR and important timelines.

All Webinars

Featured Case Study

Avoiding market access delay due to incorrect product classification

A start up company (with the help of two innovative physicians) developed a tool that provides a safer, more effective way to alleviate a common orthopedic condition.  Although early funding came at a cadence that kept progress moving steadily ahead, rounds for managing the entire life cycle to reach commercial distribution were relatively small.  But by correctly classifying the device, time to market was minimized.

All Case Studies

RCRI overview brochure    DOWNLOAD